<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Mojadidi MK</dc:creator>
  <dc:creator>Ruiz JC</dc:creator>
  <dc:creator>Chertoff J</dc:creator>
  <dc:creator>Zaman MO</dc:creator>
  <dc:creator>Elgendy IY</dc:creator>
  <dc:creator>Mahmoud AN</dc:creator>
  <dc:creator>Al-Ani M</dc:creator>
  <dc:creator>Elgendy AY</dc:creator>
  <dc:creator>Patel NK</dc:creator>
  <dc:creator>Shantha G</dc:creator>
  <dc:creator>Tobis JM</dc:creator>
  <dc:creator>Meier B</dc:creator>
  <dc:date>2019</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Patent foramen ovale (PFO), an embryonic remnant of the fetal circulation, is present in 20-25% of adults. Although recent observational studies and clinical trials have established the link between PFO-mediated right-to-left shunting with cryptogenic stroke and migraine with aura, the role of a PFO in exacerbating hypoxemic medical conditions (ie, sleep apnea, chronic obstructive pulmonary disease, pulmonary hypertension, platypnea-orthodeoxia, pulmonary arteriovenous malformation, high-altitude pulmonary edema, and exercise desaturation) remains less understood. PFO-mediated hypoxemia occurs when deoxygenated venous blood from the right atrium enters and mixes with oxygenated arterial blood in the left atrium. Patients with an intracardiac right-to-left shunt may have profound hypoxemia out of proportion to underlying primary lung disease, even in the presence of normal right-sided pressures. The presence of right-to-left cardiac shunting can exacerbate the degree of hypoxemia in patients with underlying pulmonary disorders. In a subset of these patients, percutaneous PFO closure may result in marked improvement in dyspnea and hypoxemia. This review discusses the association between PFO-mediated right-to-left shunting with medical conditions associated with hypoxemia and explores the role of percutaneous PFO closure in alleviating the hypoxemia.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/201501</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1097/CRD.0000000000000205</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/29570476</dc:relation>
  <dc:source>Cardiology in review. - 2019</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Endovascular Procedures</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Foramen Ovale, Patent</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Hypoxia</dc:subject>
  <dc:title xmlns:ns5="xml" ns5:lang="en">Patent Foramen Ovale and Hypoxemia.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
